K Kannan

874 total citations
51 papers, 715 citations indexed

About

K Kannan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K Kannan has authored 51 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K Kannan's work include Cancer-related Molecular Pathways (7 papers), Arsenic contamination and mitigation (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). K Kannan is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Arsenic contamination and mitigation (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). K Kannan collaborates with scholars based in India, Japan and Australia. K Kannan's co-authors include Santosh Kumar Mishra, G. Shanmugam, Vishakha Singh, Souvendra Nath Sarkar, Thakur Uttam Singh, Subhashree Parida, Soumen Choudhury, Nobuo Tsuchida, Arasambattu Kannan Munirajan and Manickam Kesavan and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and European Journal of Cancer.

In The Last Decade

K Kannan

48 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Kannan India 17 255 94 88 82 74 51 715
Hsiao-Ling Cheng Taiwan 17 329 1.3× 149 1.6× 88 1.0× 73 0.9× 14 0.2× 27 739
Suck-Young Choe South Korea 5 122 0.5× 91 1.0× 36 0.4× 61 0.7× 12 0.2× 9 642
Sapana Kushwaha India 18 355 1.4× 61 0.6× 103 1.2× 134 1.6× 12 0.2× 47 1.0k
Wenfeng Xu China 9 304 1.2× 41 0.4× 49 0.6× 97 1.2× 21 0.3× 28 837
Valéria Helena Alves Cagnon Brazil 21 411 1.6× 128 1.4× 63 0.7× 38 0.5× 21 0.3× 102 1.2k
Sanjay Khattri India 18 190 0.7× 55 0.6× 90 1.0× 44 0.5× 41 0.6× 47 696
Mohamed Tahar Yacoubi Tunisia 17 221 0.9× 115 1.2× 66 0.8× 66 0.8× 26 0.4× 53 893
Kevin J. Trouba United States 10 295 1.2× 60 0.6× 29 0.3× 26 0.3× 194 2.6× 16 620
Omid Farshad Iran 19 127 0.5× 101 1.1× 90 1.0× 98 1.2× 18 0.2× 40 753
Hamidreza Mohammadi Iran 16 126 0.5× 82 0.9× 89 1.0× 96 1.2× 10 0.1× 35 655

Countries citing papers authored by K Kannan

Since Specialization
Citations

This map shows the geographic impact of K Kannan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Kannan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Kannan more than expected).

Fields of papers citing papers by K Kannan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Kannan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Kannan. The network helps show where K Kannan may publish in the future.

Co-authorship network of co-authors of K Kannan

This figure shows the co-authorship network connecting the top 25 collaborators of K Kannan. A scholar is included among the top collaborators of K Kannan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Kannan. K Kannan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kannan, K, et al.. (2023). Design and analysis of two wheeler bumper made from alkali treated natural fibers reinforced epoxy composites. AIP conference proceedings. 2782. 20174–20174. 1 indexed citations
3.
Kannan, K, et al.. (2020). Pharmacokinetics of Ivermectin (Noromectin®) Following Single Dose Subcutaneous Administration in Sheep. International Journal of Current Microbiology and Applied Sciences. 9(6). 4236–4246. 1 indexed citations
4.
Yu, Jie, Yukie Kashima, Shun‐Ichiro Kageyama, et al.. (2020). A CDC7-selective Inhibitor, TAK-931, suppresses homologous recombination repair activity to enhance antiproliferative activity of a PARP inhibitor. European Journal of Cancer. 138. S36–S36. 1 indexed citations
5.
Parida, Subhashree, Thakur Uttam Singh, Manjit Panigrahi, et al.. (2015). Daidzein pretreatment improves survival in mouse model of sepsis. Journal of Surgical Research. 197(2). 363–373. 13 indexed citations
6.
Lingaraju, Madhu Cholenahalli, Nitya Nand Pathak, Jubeda Begum, et al.. (2015). Betulinic acid attenuates renal oxidative stress and inflammation in experimental model of murine polymicrobial sepsis. European Journal of Pharmaceutical Sciences. 70. 12–21. 43 indexed citations
7.
Kannan, K, et al.. (2014). Subchronic Arsenic Exposure Through Drinking Water Alters Vascular Redox Homeostasis and Affects Physical Health in Rats. Biological Trace Element Research. 162(1-3). 234–241. 12 indexed citations
8.
Choudhury, Soumen, et al.. (2014). Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats. Toxicology and Applied Pharmacology. 280(3). 443–454. 39 indexed citations
9.
Kesavan, Manickam, et al.. (2014). Arsenic decreases antinociceptive activity of paracetamol: Possible involvement of serotonergic and endocannabinoid receptors. Environmental Toxicology and Pharmacology. 38(2). 397–405. 8 indexed citations
10.
Kannan, K, et al.. (2014). Arsenic reduces the antipyretic activity of paracetamol in rats: Modulation of brain COX-2 activity and CB1 receptor expression. Environmental Toxicology and Pharmacology. 37(1). 438–447. 13 indexed citations
11.
Sankar, Palanisamy, A.G. Telang, Manickam Kesavan, et al.. (2013). Immunomodulatory effects of nanocurcumin in arsenic-exposed rats. International Immunopharmacology. 17(1). 65–70. 33 indexed citations
13.
Huck, Jessica J., et al.. (2010). 75 The Aurora A kinase inhibitor MLN8237 in combination with docetaxel induces synergistic antitumor activity in triple-negative breast cancer xenograft models. European Journal of Cancer Supplements. 8(7). 32–32. 1 indexed citations
14.
Kannan, K, et al.. (2009). Preliminary immunomodulatory activities of aqueous extract of Morus alba Linn.. International Journal of Chemical Sciences. 7(4). 2233–2238. 11 indexed citations
15.
Slavin, Monica A., K Kannan, Malcolm Buchanan, Joseph Sasadeusz, & Andrew W. Roberts. (2002). Successful Allogeneic Stem Cell Transplant after Invasive Pulmonary Zygomycosis. Leukemia & lymphoma. 43(2). 437–439. 9 indexed citations
16.
Krishnamurthy, Jairam, et al.. (2001). Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Oral Oncology. 37(3). 222–224. 22 indexed citations
17.
Kannan, K, et al.. (2000). FHIT Gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncology. 36(2). 189–193. 13 indexed citations
18.
Kannan, K, et al.. (1999). Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in Indian myelodysplastic syndrome.. PubMed. 11(2). 101–4. 2 indexed citations
19.
Munirajan, Arasambattu Kannan, K Kannan, V. Bhuvarahamurthy, et al.. (1998). The Status of Human Papillomavirus and Tumor Suppressor Genesp53andp16in Carcinomas of Uterine Cervix from India. Gynecologic Oncology. 69(3). 205–209. 31 indexed citations
20.
Kannan, K, et al.. (1991). Effect of sewage pollution on the health status of sewage farm workers. Bulletin of Environmental Contamination and Toxicology. 47(5). 646–652. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026